Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HEL/NANOFH stock hub

HEL/NANOFH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

HEL/NANOFHis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
52.6M
Nasdaq Helsinki
Market data

Price

Recent price action with selectable time range.

HEL/NANOFHHEL/NANOFH
—
Loading chart…
In the news

Latest news · HEL/NANOFH

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-34.8
P25 n/aP50 n/aP75 n/a
ROIC-22.6
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All HEL/NANOFH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
180
Groups with data
11
Currency
EUR
Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Finland
Country code
FI
Employees
171
Employees Change
-10%
Employees Change Percent
-5.52
Enterprise value
EUR 34.8M
Exchange
Nasdaq Helsinki
Financial currency
EUR
First seen
2026-05-10
Industry
Biotechnology
Isin
FI4000330972
Last refreshed
2026-05-10
Market cap
EUR 52.6M
Price
EUR 0.61
Price currency
EUR
Rev Per Employee
29,368.42x
Sector
Healthcare
Sic
8731
Symbol
hel/NANOFH
Website
https://www.nanoform.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-34.03%
EV Earnings
-1.94x
EV/FCF
-1.86x
EV/Sales
6.93x
FCF yield
-35.54%
P/B ratio
1.23x
P/S ratio
10.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

17
MetricValue
Gross margin
89.98%
Gross Profit
EUR 4.5M
Gross Profit Growth
45.26%
Gross Profit Growth Q
74.2%
Gross Profit Growth3 Y
12.82%
Gross Profit Growth5 Y
56.21%
Net Income
EUR -17.9M
Net Income Growth Quarters
2%
Net Income Growth Years
1%
Pretax Margin
-355.79%
Profit Per Employee
EUR -104,667
ROA
-20.62
Roa5y
-16.81
ROCE
-43.38
ROE
-34.82
Roe5y
-30.22
ROIC
-22.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr1y
-37.24%
Cagr3y
-34.14%
Cagr5y
-38%
EPS Growth Quarters
1
EPS Growth Years
1
Revenue Growth
37.1x
Revenue Growth Q
72.19x
Revenue Growth Quarters
1x
Revenue Growth Years
2x
Revenue Growth3 Y
12.93x
Revenue Growth5 Y
48.22x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
EUR 0.08
Assets
EUR 54M
Cash
EUR 24M
Current Assets
EUR 26.5M
Current Liabilities
EUR 6.1M
Debt
EUR 6.2M
Debt Equity
EUR 0.15
Debt FCF
EUR -0.33
Equity
EUR 42.8M
Interest Coverage
-494
Liabilities
EUR 11.2M
Long Term Assets
EUR 27.5M
Long Term Liabilities
EUR 5.1M
Net Cash
EUR 17.8M
Net Cash By Market Cap
EUR 33.83
Net Cash Growth
-50.43%
Net Debt Equity
EUR -0.42
Tangible Book Value
EUR 42.2M
Tangible Book Value Per Share
EUR 0.49
WACC
6.59

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
4.31
Inventory Turnover
2.14
Net Working Capital
EUR -2.3M
Quick ratio
4.21
Working Capital
EUR 20.4M
Working Capital Turnover
EUR 0.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-2.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-37.22%
200-day SMA
0.88
3Y total return
-71.44%
50-day SMA
0.58
50-day SMA vs 200-day SMA
50under200
5Y total return
-90.84%
All Time High
8.8
All Time High Change
-93.02%
All Time High Date
2021-02-24
All Time Low
0.38
All Time Low Change
62.86%
All Time Low Date
2026-03-31
ATR
0.05
Beta
0.56
Beta1y
0.41
Beta2y
0.25
Ch YTD
-47.61
High
0.66
High52
1.38
High52 Date
2025-10-01
High52ch
-55.57%
Low
0.58
Low52
0.38
Low52 Date
2026-03-31
Low52ch
62.87%
Ma50ch
5.23%
Price vs 200-day SMA
-30.43%
RSI
61.58
RSI Monthly
37.74
RSI Weekly
39.13
Sharpe ratio
-0.32x
Sortino ratio
-0.44
Total Return
-2.76%
Tr YTD
-47.61
Tr1m
41.15%
Tr1w
27.92%
Tr3m
-27.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -20.7M
Operating margin
-413.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
24,622,612%
Net Borrowing
-6,000
Shares Insiders
14.33%
Shares Institutions
40.08%
Shares Out
85,669,853
Shares Qo Q
14.64%
Shares Yo Y
2.76%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

52
MetricValue
Adjusted FCF
EUR -19.2M
Average Volume
263,695x
Bv Per Share
0.5
CAPEX
EUR -1M
Ch1m
41.15
Ch1w
27.92
Ch1y
-37.22
Ch3m
-27.59
Ch3y
-71.44
Ch5y
-90.84
Ch6m
-43.04
Change
0.99%
Change From Open
-0.97
Close
0.61
Days Gap
1.97
Depreciation Amortization
1,926,000
Dollar Volume
125,187.8
Earnings Date
2026-05-19
EBIT
EUR -20.7M
EBITDA
EUR -18.8M
EPS
EUR -0.21
F Score
3
FCF
EUR -18.7M
FCF EV Yield
-53.71x
FCF Per Share
EUR -0.22
Financing CF
120,000
Fiscal Year End
December
Founded
2,008
Income Tax
EUR 30,000
Investing CF
5,090,000
Is Primary Listing
1
Last Earnings Date
2026-02-26
Last Report Date
2025-12-31
Ma150
0.86
Ma150ch
-28.98%
Ma20
0.53
Ma20ch
15.44%
Net CF
-12,469,000
Next Earnings Date
2026-05-19
Open
0.62
Position In Range
44.58
Ppne
24,321,000
Price Date
2026-05-08
Ptbv Ratio
1.25
Relative Volume
0.78x
Revenue
5,022,000x
SBC By Revenue
10.77x
Share Based Comp
541,000
Tax By Revenue
0.6x
Tr6m
-43.04%
Volume
203,889
Z Score
0.91
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does HEL/NANOFH pay a dividend?

Capital-return profile for this ticker.

Performance

HEL/NANOFH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-37.2%
S&P 500 1Y: n/a
3Y total return
-71.4%
S&P 500 3Y: n/a
5Y total return
-90.8%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns HEL/NANOFH?

Insider, institutional, and short-interest positioning.

Institutional ownership
+40.1%
Share of float held by funds and institutions
Insider ownership
+14.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+2.8%
Negative means the company is buying back shares.
Technical

HEL/NANOFH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
61.6
Neutral momentum band
Price vs 200-day MA
-30.4%
50/200-day relationship not available
Beta (5Y)
0.56
Less volatile than the market
Sharpe ratio
-0.32
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About HEL/NANOFH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hel/NANOFH stock rating?

hel/NANOFH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hel/NANOFH analysis?

The full report lives at /stocks/hel/NANOFH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hel/NANOFH?

The latest report frames hel/NANOFH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hel/NANOFH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.